Ninety-four percent of global institutional investors expect to maintain or increase their Canadian exposure over the next ...

CC&L Financial Group and Leith Wheeler operate under different models but agree that ownership drives how managers serve plan ...

Medavie Blue Cross' first drug trends report reveals weight management as the lead cost driver, with no signs of uptake ...

PwC divides respondents into front-runners at 14 percent, with scarce skills and strong AI capabilities; AI insurgents at 18 ...

Adults who switched from injectable GLP-1 medicines to the once-daily Wegovy pill lost an average of 4.1 percent of their body weight, or 4.0 kg (8.8 lb), over three months in the OCTANE study ...

Treasuries near 5.24% lift discount rates and reset how plan sponsors value liabilities Canada's 10-year bond yield reached 3 ...

Semaglutide, sold as Ozempic, Rybelsus and Wegovy, topped the list of drug products by cost in the 2026 GreenShield Drug ...

Attendees say this year's ACPM conference sharpened the focus on pension policy and retirement income solutions ...

Ottawa is weighing when to resume a "controlled increase" in Canada's population, just over a month before it is required by ...

Capgemini research shows Canadians are confident in workplace coverage they don't understand, and the benefits industry ...

Pension fund's $441 million deal for Prestige Hospitality Ventures marks its first direct hospitality investment in India ...

"I am very pleased to see David assume the role of president of Letko Brosseau & Associates, which represents a natural ...